Categories: RIM

A look at the balance sheet of Research in Motion (TSX:RIM)

No respect. It’s hard to imagine that Research in Motion has become the Rodney Dangerfield of tech stocks. Just two years ago it seemed every analyst in the country was behind the company and its prospects. That country was, of course, The United States, home to Apple, Google, and Palm, who some nervy analysts are now actually comparing the Blackberry maker to. Is this a cultural thing? A few weeks ago Bloomberg reported on a growing divide between the way US and Canadian analysts saw the stock, which is now trading near a three year low. They noted that ten of eleven Canadian analysts who cover the stock rate it a buy, while just 54 percent of the 35 U.S. analysts covering the stock do. Investors following analysts who see RIM as a sloth in the world of iPhones and Androids might be surprised at the Waterloo giant’s numbers. It was just a year ago that Fortune named the company the fastest growing company in the world, and Research in Motion hasn’t yet taken its foot off the pedal, posting 24% top line growth in its Q1 2011 numbers, reported in late June. Is it possible that Research in Motion is now both a growth and a value stock? With the RIM stock chart showing a beaten up stock, we break down the numbers in an updated Quant Snapshot: Research in Motion (TSX:RIM).

1. Price to Sales: 1.56 x sales

As of Friday, September 3rd, Research in Motion had 552 million shares outstanding. The price, as of the same date, was $44.78. (Note: We have used the price of RIM’s NASDAQ listing because the company’s financials are reported in US Dollars) This gave The Company a market capitalization of $24.7 billion. In the trailing four quarters RIM posted sales of $15.74 billion.

2. Cash to Market Cap: 9.47%

As of Q1, 2011 (May 29th, 2010) RIM had a Cash and Short Term Investments position of $2.34 billion. The Company’s Market Capitalization, as of Friday, September 3rd was $24.7 billion.

3. Debt to Market Cap: Zero

As of Q1, 2011 (May 29th, 2010) RIM had no Long Term Debt.

4. Three Year Growth: 72.2%

Revenue was $3.03 million in FY 2007. This grew to $14.9 billion in FY 2010.

5. Enterprise Value to Sales: 1.42 x Sales

RIM’s Enterprise Value is $22.36 billion based on a market capitalization of $24.7 billion, plus Long Term Debt of Zero, minus Cash and Short Term Investments of $2.34 billion. In the trailing four quarters, sales totaled $15.74 billion.

All financial information about RIM is gleaned from

their filings with the System for Electronic Document Analysis and

Retrieval (SEDAR)

All calculations are based on The Company’s closing share price as of

close September 3rd, 2010: $44.78

Sales from trailing four quarters: $15.74 billion

Cash and Short Term Investments as of Q1, 2011 (May 29th, 2010): $2.34 billion

Shares outstanding: 552 million

Tagged with: rim
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Tilray: why this analyst just cut his price target

Haywood Securities analyst Neal Gilmer says lower Canadian cannabis market share is weighing on Tilray Brands (Tilray Brands Stock Quote,… [Read More]

22 hours ago

Why National Bank likes Anaergia right now

National Bank Financial analyst Baltej Sidhu says Anaergia’s (Anaergia Stock Quote, Chart, News, Analysts, Financials TSX:ANRG) divestiture of two legacy… [Read More]

22 hours ago

Canada’s provinces are leading investment boom, RBC says

RBC assistant chief economist Cynthia Leach says the public sector is playing a larger role in Canada’s investment boom than… [Read More]

22 hours ago

Can Eupraxia Pharmaceuticals stock go even higher?

Research Capital analyst Andre Uddin says Eupraxia Pharmaceuticals (Eupraxia Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:EPRX) reported another strong… [Read More]

22 hours ago

Is it time to buy VersaBank stock?

Roth Capital Partners analyst Craig Irwin says VersaBank (VersaBank Stock Quote, Chart, News, Analysts, Financials NASDAQ:VBNK) is nearing a potential… [Read More]

23 hours ago

Rapid Micro Biosystems has a 240% upside, this analyst says

Roth Capital Partners analyst Max Masucci says Rapid Micro Biosystems (Rapid Micro Biosystems Stock Quote, Chart, News, Analysts, Financials NASDAQ:RPID)… [Read More]

23 hours ago